News & Analysis as of

Capital Markets Healthcare

Skadden, Arps, Slate, Meagher & Flom LLP

Report on Hong Kong-Listed Biotech Companies - June 2024

点击此处阅读调查报告全文 Our fourth annual report on Hong Kong-listed biotech companies examines how the sector performed during the continuing challenging market conditions of the last full calendar year. Although the number of...more

Procopio, Cory, Hargreaves & Savitch LLP

How Private Equity Firms Select Investment Targets and Build Capital: Insights for Entrepreneurs

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? Procopio Partner and Mergers &...more

Fenwick & West Life Sciences Group

In 2024, the Digital Health Revolution Continues

Digital health is showing signs of life despite financial markets that seem determined to bring some of 2023’s volatility into the new year. Stocks are up and down, and bond yields are climbing. Inflation is proving stubborn,...more

McDermott Will & Emery

Innovation in Financing: Where Are We Seeing Growth?

McDermott Will & Emery on

Meanwhile, cash-strapped biotechs have in many cases been forced to leverage relationships with big pharma to address liquidity. Cash is king in a financing environment such as we have observed over the last 18 months, and...more

McDermott Will & Emery

European Health & Life Sciences Symposium 2023 | Key Takeaways

McDermott Will & Emery on

200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more

McDermott Will & Emery

HPE Europe 2023 | Key Takeaways

McDermott Will & Emery on

240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of...more

McDermott Will & Emery

Investing in Healthcare & Life Sciences - An International Guide to Regulatory and Transactional Issues Across the Sector -...

McDermott Will & Emery on

As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more

Ankura

How Health Systems Can Use Financial Metrics to Inform Real Estate Capital Management Decisions

Ankura on

Today, maximizing the use of your limited capital is especially important because: margins continue to be squeezed, access to capital has become more difficult, the cost of capital continues to rise, the cost of...more

Ankura

A Financially Feasible Inpatient Solution is Possible… If You Are in the Right Market and Deploy the Right Strategy

Ankura on

Many health systems are not currently considering inpatient capital projects because it is incredibly difficult to generate an appropriate profit margin with the current market pressures around reimbursement, rising expenses,...more

Bass, Berry & Sims PLC

Healthcare Trends & Transactions Q2 2023

Bass, Berry & Sims PLC on

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

McDermott Will & Emery

Key Takeaways | Playing the Long Game: Investor Outlook on Late-Stage Funding

McDermott Will & Emery on

The days of funding growth at all costs are over, particularly for late-stage businesses. Investors are looking for strong unit economics at the gross-margin level, proven return on investment, customer retention and...more

White & Case LLP

US de-SPAC & SPAC data & statistics roundup

White & Case LLP on

Welcome to the White & Case US SPACs Data Hub, which provides a quarterly review and analysis of key drivers and trends behind US SPAC IPO and de-SPAC activity. ...more

Skadden, Arps, Slate, Meagher & Flom LLP

Report on Hong Kong-Listed Biotech Companies - April 2023

点击此处阅读调查报告全文 Our third annual report on Hong Kong-listed biotech companies examines how the sector performed during the challenging conditions for capital markets globally over the past 12 months. Although aggregate listing...more

McDermott Will & Emery

HPE Miami 2023 | The Best Transaction for You: Different Deal Types and Structures

McDermott Will & Emery on

During this session, the panelists discussed the various types of transaction structures and key considerations when building and executing an exit strategy....more

McDermott Will & Emery

HPE Miami 2023 | Assessing Market Conditions in the Current Economic Environment

McDermott Will & Emery on

Partner Andrea Zazulia moderated a panel during the Independent Healthcare Company Transactions Forum that focused on the ripple effects of recent market dynamics and the short- and long-term prognosis for healthcare...more

McDermott Will & Emery

HPE Miami 2023 | Hot PPM Specialties: Spotlight on Cardiology, Ortho/PT and GI

McDermott Partners Amanda Jester and Joel Rush moderated a panel discussion that examined the market trends shaping physician practice management platforms in cardiology, orthopedics and gastroenterology. The speakers also...more

McDermott Will & Emery

HPE Miami 2023 | Fundraising in a Challenging Environment

McDermott Will & Emery on

During this session, Partner Luc Jansen moderated a panel that provided an overview of the current fundraising market and offered insights into which strategies are yielding successful outcomes....more

McDermott Will & Emery

HPE Miami 2023 | Financing Healthcare Companies in a Challenging Market

McDermott Will & Emery on

During this session, Sam Koplik, Partner and Stephanie McCann, Partner and Co-Chair of Finance moderated a panel that provided key insights on financing strategies in the current market and discussed specific challenges and...more

McDermott Will & Emery

2023 Annual Health Report: Healthcare Private Equity

McDermott Will & Emery on

Private equity investment in healthcare reached an all-time high in 2022, with reports putting the overall deal value at a staggering $151 billion. But 2023 is shaping up to be a very different year, with investors pulling...more

Bass, Berry & Sims PLC

2023 Healthcare Private Equity Outlooks & Trends

As we kick off 2023, we are optimistic that the healthcare private equity (PE) market will be resilient despite various headwinds. As you think ahead, please consider the issues and trends summarized below that may be helpful...more

McDermott Will & Emery

HPE Europe 2022 | Key Takeaways

McDermott Will & Emery on

Key Trends & Opportunities in Life Sciences and Healthcare Investing - The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more

Katten Muchin Rosenman LLP

M&A, Joint Ventures and Private Equity in Health Care: 2022 Deal Trends in Review

The health care mergers and acquisitions (M&A) market continues to be a private equity draw, with investors making significant investments in standalone platforms and platform add-on transactions. Also at the fore are...more

Ankura

How Health Systems Can Flex Their Reputation Capital in Build-to-Suit Outpatient Projects

Ankura on

Physicians Realty Trust, a healthcare real estate investment trust (REIT) with a strong focus on medical office buildings (MOBs), reported 99% rent collection in Q2 2021, an incredible achievement especially during a...more

McDermott Will & Emery

Value Investing Forum 2022 Interactive Case Studies: Hot Sectors in Value Investing

McDermott Will & Emery on

In this session, Felicia Perlman, Partner & Head of McDermott’s Business Restructuring Practice Group, and Fred Levenson, Partner & Co-Head of McDermott’s Private Equity Practice Group, moderated a discussion that explored...more

McDermott Will & Emery

HPE Miami 2022 Financing Healthcare Deals: Strategies for the Year Ahead

In this session, Stephanie McCann, Partner and Co-Head of McDermott’s Finance Practice, led a wide-ranging discussion of critical strategies for investors to consider as they seek sources of capital to finance healthcare...more

38 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide